DXR on Nasdaq

DAXOR CORP

DAXOR CORP is a corporation registered in the United States, active since 1971.² It is headquartered in Oak Ridge, United States.² Its shares trade on Nasdaq under the symbol DXR.²

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

TickerDXR on Nasdaq²
HeadquartersOak Ridge, United States²
Incorporated inNY³
Business address107 Meco Lane, Oak Ridge, Tn 37830³
Legal formBusiness Corporation²
LEI984500B839ED8XIK6792²
StatusActive²
LEI statusLapsed (not renewed)²
Registered address109 MECO LANE, 37830 Oak Ridge, United States²
Registered withCorporation and Business Entity Database (Division of Corporations, State Records and UCC, Department of State), 307277²

See how the biggest companies compare on our leaderboards

What it owns

What DAXOR CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, net	$4.0M⁴ Dec 31, 2011	$4.2M⁴ Dec 31, 2010	−4.0%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$59.6K⁴ Dec 31, 2011	$57.7K⁴ Dec 31, 2010	+3.3%

Inventory

Item	Latest	A year before	Change
Inventory, total	$301.5K⁴ Dec 31, 2011	$363.6K⁴ Dec 31, 2010	−17.1%

Leadership

Who has led DAXOR CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

Chair

President

2010201520202025

Chief executive officerMichael Richard Feldschuh Apr 12, 2016 to now⁵
Chief executive officerJoseph Feldschuh Jul 28, 2009 to Apr 6, 2015⁶
ChairMichael Richard Feldschuh Jul 13, 2023 to Jul 13, 2023⁷
ChairJoseph Feldschuh Apr 19, 2016 to Jan 9, 2017⁸
PresidentMichael Richard Feldschuh Apr 12, 2016 to Jul 13, 2023⁵
PresidentJoseph Feldschuh Jan 23, 2006 to Apr 6, 2015⁹

Board members and other officers (19)

Chief Medical OfficerJohn Jefferies Oct 2, 2025 to now¹⁰
V.P./BUSINESS DEVELOPMENTSoren Thompson Mar 24, 2017 to Aug 2, 2018¹¹
CHIEF SCIENTIFIC OFFICERJonathan Adam Feldschuh Mar 27, 2017 to now¹²
Corporate SecretaryDiane Marie Meegan Feb 19, 2015 to Apr 13, 2015¹³
Executive VPMichael Richard Feldschuh Jul 27, 2015 to Apr 7, 2016¹⁴
Vice PresidentEveris Engstrom Dec 5, 2008 to Dec 5, 2008¹⁵
Board memberCaleb Desrosiers Jan 28, 2022 to now¹⁶
Board memberHenry D. Cremisi Jul 9, 2020 to now¹⁷
Board memberJoy S. Goudie Jul 9, 2020 to now¹⁸
Board memberJames A. Lombard Jul 29, 2020 to Jul 13, 2023¹⁹
Board memberEdward Feuer Jul 16, 2018 to now²⁰
Board memberJonathan Adam Feldschuh Mar 27, 2017 to now¹²
Board memberBernhard Saxe Apr 23, 2014 to Jul 9, 2020²¹
Board memberMichael Richard Feldschuh Oct 21, 2013 to now²²
Board memberMartin S. Wolpoff Nov 19, 2008 to Jul 15, 2020²³
Board memberJoseph Feldschuh Feb 12, 2007 to Apr 6, 2015²⁴
Board memberPhilip Nordan Hudson Feb 16, 2006 to Mar 28, 2012²⁵
Board memberRobert G. Moussa Jun 20, 2006 to Oct 31, 2006²⁶
Board memberRobert Willens Nov 17, 2006 to May 10, 2013²⁷

Timeline

Jun 24, 20268-K Shareholder vote²⁸
Jan 26, 20268-K Entered a material agreement; Other events²⁹
Jan 23, 20268-K Other events³⁰
Aug 7, 20258-K Other events³¹
Jul 1, 20258-K Shareholder vote³²
Jul 18, 20248-K Shareholder vote³³
Jun 5, 20248-K Listing notice or transfer³⁴
Mar 25, 20248-K Other events³⁵
Jan 2, 20248-K Other events³⁶
Nov 28, 20238-K Other events³⁷
Oct 27, 20238-K Other events³⁸
Jul 13, 20238-K Shareholder vote³⁹
Apr 12, 2016New chief executive Michael Richard Feldschuh becomes CEO⁵
Jul 28, 2009New chief executive Joseph Feldschuh becomes CEO⁶
May 5, 1971Founded DAXOR CORP is founded²

Filings

174 filings to the SEC since October 2021: 18 major events, 61 insider forms, 95 other. The latest 20:

Oct 9, 202640-8F-2/A APPLICATION FOR DEREGISTRATION MADE ON FORM N-8F EDGAR
Sep 24, 2026N-CEN/A EDGAR
Sep 4, 202640-8F-2/A APPLICATION FOR DEREGISTRATION MADE ON FORM N-8F EDGAR
Sep 1, 20264 EDGAR
Aug 31, 2026NPORT-P EDGAR
Aug 31, 2026N-CSR EDGAR
Aug 31, 2026N-PX EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 25, 20264 EDGAR
Jun 24, 20268-K EDGAR
Jun 17, 202640-8F-2/A EDGAR
Jun 3, 2026DEF 14A EDGAR
Jun 2, 2026NT NPORT-P EDGAR
May 21, 202640-8F-2/A EDGAR
May 11, 202640-17F2 EDGAR

The 174 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

28 open-market trades by officers, directors and large owners since October 2021: 28 buys and 0 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Apr 8, 2026	Feldschuh Michael RichardChief Executive Officer	Buy	1,000	$9.07	$9.1K	Form 4
Mar 31, 2026	Michel Robert JChief Financial Officer	Buy	1,000	$9.90	$9.9K	Form 4
Mar 20, 2026	Jefferies JohnChief Medical Officer	Buy	5,941			Form 4
Dec 9, 2025	Michel Robert JChief Financial Officer	Buy	3,000			Form 4
Dec 9, 2025	Feldschuh Jonathan AdamChief Scientific Officer	Buy	18,000			Form 4
Nov 12, 2025	Jefferies JohnChief Medical Officer	Buy	2,344			Form 4
Apr 4, 2025	Feldschuh Michael RichardChief Executive Officer	Buy	2,063	$7.89	$16.3K	Form 4
Mar 10, 2025	Michel Robert JChief Financial Officer	Buy	1,000	$8.00	$8.0K	Form 4
Mar 10, 2025	Feldschuh Michael RichardChief Executive Officer	Buy	3,360	$7.68	$25.8K	Form 4
Dec 6, 2024	Feldschuh Jonathan AdamChief Scientific Officer	Buy	32,000			Form 4
Dec 6, 2024	Feldschuh Michael RichardChief Executive Officer	Buy	45,000			Form 4
Mar 27, 2024	Michel Robert JChief Financial Officer	Buy	750	$8.70	$6.5K	Form 4
Mar 26, 2024	Feldschuh Michael RichardChief Executive Officer	Buy	1,000	$8.13	$8.1K	Form 4
Mar 19, 2024	Feldschuh Michael RichardChief Executive Officer	Buy	647	$8.15	$5.3K	Form 4
Mar 10, 2024	Feldschuh Michael RichardChief Executive Officer	Buy	1,492	$7.72	$11.5K	Form 4
Mar 4, 2024	Feuer EdwardDirector	Buy	1,000	$7.21	$7.2K	Form 4
Dec 6, 2023	Michel Robert JChief Financial Officer	Buy	120	$7.75	$930	Form 4
Dec 1, 2023	Michel Robert JChief Financial Officer	Buy	180	$7.75	$1.4K	Form 4
Dec 1, 2023	Feldschuh Michael RichardChief Executive Officer	Buy	800	$7.80	$6.2K	Form 4
Nov 24, 2023	Michel Robert JChief Financial Officer	Buy	500	$7.94	$4.0K	Form 4

All 28 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Vanguard Capital Management LLC	48,831	$495.6K	0.0%	+551
Aristides Capital LLC	41,689	$429.2K	0.1%	−3
Renaissance Technologies LLC	29,421	$302.9K	0.0%	+1,410
Susquehanna International Group, Llp	27,131	$275.4K	0.0%	+13,411
Nano Cap New Millennium Growth Fund L P	12,500	$128.7K	0.1%	No change
Crescent Grove Advisors, LLC	12,423	$127.9K	0.0%	+1,700
SBI Securities Co., Ltd.	3,131	$32.2K	0.0%	+3
Morgan Stanley	3,087	$31.8K	0.0%	No change
Vanguard Fiduciary Trust Co	1,037	$10.5K	0.0%	No change
Osaic Holdings, Inc.	500	$5.1K	0.0%	No change
Tower Research Capital LLC (TRC)	305	$3.1K	0.0%	+196
Thompson Siegel & Walmsley LLC	241,767	$2.5K	0.0%	+9,647
UBS Group AG	172	$1.8K	0.0%	New
Jpmorgan Chase & Co	6	$61	0.0%	+5
Wells Fargo & Company/mn	0	$2	0.0%	No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How DAXOR CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARDAXOR CORP¹
CIK0000027367
Employer ID (EIN)13-2682108¹
Incorporated inNew York¹
Fiscal year endsDecember 31¹
Business address107 Meco Lane, Oak Ridge, TN 37830¹
Phone865-425-0555¹
Shares outstanding4,196,182 as of Mar 22, 2012⁴
Public float$10.1M as of Jun 30, 2011⁴
On EDGAR sinceApr 18, 1995¹
Filings736 in all: 4 (267), 10-Q (51), 40-17F2 (38), 8-K (37), DEF 14A (28), CORRESP (27), N-CSR (19), 10-K (18)¹
All 62 form types
N-Q (16), NPORT-P (16), N-PX (14), 10-Q/A (12), 3 (11), 497 (11), 40-17G (10), N-2/A (10), N-CSRS (10), N-CEN (8), N-CEN/A (8), UPLOAD (8), N-CSR/A (7), 10-K/A (6), 5 (6), NSAR-A (6), NT 10-Q (6), 40-17F2/A (5), EFFECT (5), POS 8C (5), SC 13G (5), 40-8F-2/A (4), N-2 (4), NSAR-B (4), NSAR-B/A (4), NT 10-K (4), NT-NCSR (4), NT NPORT-P (3), NT-NSAR (3), SC 13G/A (3), 144 (2), 4/A (2), 40-APP/A (2), 424B3 (2), 8-K/A (2), DEFR14A (2), N-PX/A (2), NT-NCSR/A (2), S-8 (2), 25 (1), 40-8F-2 (1), 40-APP (1), 424B4 (1), 8-A12B (1), APP NTC (1), APP ORDR (1), CERT (1), N-8A (1), NSAR-A/A (1), NTN 10Q (1), POS AMI (1), POS EX (1), RW (1), S-3 (1)
Latest filingsAnnual report (10-K) Mar 28, 2012
Quarterly report (10-Q) Nov 14, 2011
Proxy statement (DEF 14A) Jun 3, 2026
Latest 8-K (8-K) Jun 24, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDAXOR CORP filings on SEC EDGAR
2
GLEIFDAXOR CORP LEI record (984500B839ED8XIK6792)
3
SEC EDGARDAXOR CORP filings on SEC EDGAR
4
SEC EDGARDAXOR CORP 10-K for fiscal 2011
5
SEC EDGARMichael Richard Feldschuh, Chief executive officer
6
SEC EDGARJoseph Feldschuh, Chief executive officer
7
SEC EDGARMichael Richard Feldschuh, Chair
8
SEC EDGARJoseph Feldschuh, Chair
9
SEC EDGARJoseph Feldschuh, President
10
SEC EDGARJohn Jefferies, Chief Medical Officer
11
SEC EDGARSoren Thompson, V.P./BUSINESS DEVELOPMENT
12
SEC EDGARJonathan Adam Feldschuh, CHIEF SCIENTIFIC OFFICER
13
SEC EDGARDiane Marie Meegan, Corporate Secretary
14
SEC EDGARMichael Richard Feldschuh, Executive VP
15
SEC EDGAREveris Engstrom, Vice President
16
SEC EDGARCaleb Desrosiers, Board member
17
SEC EDGARHenry D. Cremisi, Board member
18
SEC EDGARJoy S. Goudie, Board member
19
SEC EDGARJames A. Lombard, Board member
20
SEC EDGAREdward Feuer, Board member
21
SEC EDGARBernhard Saxe, Board member
22
SEC EDGARMichael Richard Feldschuh, Board member
23
SEC EDGARMartin S. Wolpoff, Board member
24
SEC EDGARJoseph Feldschuh, Board member
25
SEC EDGARPhilip Nordan Hudson, Board member
26
SEC EDGARRobert G. Moussa, Board member
27
SEC EDGARRobert Willens, Board member
28
SEC EDGARShareholder vote
29
SEC EDGAREntered a material agreement; Other events
30
SEC EDGAROther events
31
SEC EDGAROther events
32
SEC EDGARShareholder vote
33
SEC EDGARShareholder vote
34
SEC EDGARListing notice or transfer
35
SEC EDGAROther events
36
SEC EDGAROther events
37
SEC EDGAROther events
38
SEC EDGAROther events
39
SEC EDGARShareholder vote